-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Iovance Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2020 to Q2 2024.
- Iovance Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 285K shares, a 26.9% increase year-over-year.
- Iovance Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 235K shares, a 47.6% increase from 2022.
- Iovance Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 159K shares, a 3.82% increase from 2021.
- Iovance Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 153K shares, a 10.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)